跳至主要内容
临床试验/ACTRN12617001639314
ACTRN12617001639314招募中不适用

A randomised controlled trial of sulindac to delay premature birth in pregnancies complicated by a short cervix

The Royal Women's Hospital0 个研究点目标入组 40 人开始时间: 2017年12月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • -Gestation 18+0/40 - 23+6/40 weeks by EDD established according to RWH guidelines
  • -Consent to sonographic estimation of AFI (Amniotic Fluid Index) scores
  • -Cervical length 0-15mm on transvaginal ultrasonography, performed using a standardised technique14
  • -Singleton pregnancy
  • -Has received treatment with vaginal progesterone pessaries
  • -Has received treatment with cervical cerclage
  • -Has been submitting to recommended ‘bed rest’

排除标准

  • -Gestation outside 18+0/40 - 23+6/40 week range
  • -Multiple pregnancy
  • -Cervical length greater than 15mm
  • -Known allergy to sulindac
  • -Pre-existing oligohydramnios / AFI <10 cm
  • -Pre-existing clinical chorioamnionitis
  • -Inability to provide informed consent
  • -History of any contraindications to NSAIDS, including: acute dehydration, NSAID-sensitive asthma, coagulation disorders, heart failure, active peptic ulcer disease or GI bleeding, renal impairment / CrCl<25mL/min.

研究者

发起方
The Royal Women's Hospital

相似试验

A randomised controlled trial of sulindac to delay... | 临床试验